Taking life science to the stock market

AstraZeneca, Pepparedsleden 5, Göteborg
15.00 - 19.30

Join us and your life science colleagues for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value.

This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017.


3.00 pm — 3:30 pm Coffee and Registration
3:30 pm — 3:35 pm Welcome and introduction
3.35 pm — 3:45 pm Latest trends in biotech funding
3.45 pm — 4:05 pm Inside the head of a life science investor
4.05 pm — 5:00 pm What’s the best way for a small life science company to raise capital to generate big value?
5.00 pm — 6:00 pm Networking and bell-ringing
6.00 pm — 7:30 pm Nasdaq surgery session



We’d love for this to be an interactive event based on dialogue between the presenters and audience.

You’re welcome to let us know in advance if there are any particular topics or questions you’d like to ask any of the presenters/panelists. Send us an email at bioventurehub@astrazeneca.com.

And, of course, feel free to ask lots of questions at the event.


Adam Kostyal, Nasdaq

Carl Bennet, Carl Bennet AB

Charlotta Gummeson, Sahlgrenska Science park

Erik Gatenholm, Cellink

Homan Panahi, Vator Securities

Johannes Hulthe, Antaros Medical

Klementina Österberg, GU Ventures

magnus Björsne, AZ BioVentureHub